Abstract:PurposeTo assess the efficacy of a newly designed retrievable drug eluting stent for the treatment of benign cardia stricture in a canine model versus group that received bare stent insertion.Materials and MethodsForty-eight achalasia-like dog models were randomly divided into a control group (CG; no stent insertion), a bare stent group (BSG, n=16) and a drug eluting stent group (BESG, n=16). All stents were retrieved four days after insertion. Lower-esophageal-sphincter pressures (LESP) and the 5-min barium height (5-mBH) were assessed before and immediately after the procedure, and at 1-week, 1-, 3- and 6-month follow-up. Four dogs in each group were sacrificed for histological examination.ResultsCardia stent insertion was tolerated by all subjects, with similar stent migration rate of DES or BS (5.6% vs. 11.1%; P=0.3636). At the 6-month follow-up, the values of LESP and 5-mBH in the BESG is more stable compared to those in the BSG (p<0.05). Immunohistochemistry for mouse anti-proliferating cell nuclear antigen (PCNA) and α-smooth muscle actin revealed alleviate inflammatory reaction peak in the BESG than in the BSG (p<0.05). Collagen proliferation was most severe after 6 months in the BSG (p<0.05).ConclusionThe novel drug eluting cardia stent was more effective than bare stent for the treatment of this benign cardia stricture canine model. Further studies are required to assess if the recurrence rate is lower due to less inflammation and scarring in a long-term. PurposeTo assess the efficacy of a newly designed retrievable drug eluting stent for the treatment of benign cardia stricture in a canine model versus group that received bare stent insertion. To assess the efficacy of a newly designed retrievable drug eluting stent for the treatment of benign cardia stricture in a canine model versus group that received bare stent insertion. Materials and MethodsForty-eight achalasia-like dog models were randomly divided into a control group (CG; no stent insertion), a bare stent group (BSG, n=16) and a drug eluting stent group (BESG, n=16). All stents were retrieved four days after insertion. Lower-esophageal-sphincter pressures (LESP) and the 5-min barium height (5-mBH) were assessed before and immediately after the procedure, and at 1-week, 1-, 3- and 6-month follow-up. Four dogs in each group were sacrificed for histological examination. Forty-eight achalasia-like dog models were randomly divided into a control group (CG; no stent insertion), a bare stent group (BSG, n=16) and a drug eluting stent group (BESG, n=16). All stents were retrieved four days after insertion. Lower-esophageal-sphincter pressures (LESP) and the 5-min barium height (5-mBH) were assessed before and immediately after the procedure, and at 1-week, 1-, 3- and 6-month follow-up. Four dogs in each group were sacrificed for histological examination. ResultsCardia stent insertion was tolerated by all subjects, with similar stent migration rate of DES or BS (5.6% vs. 11.1%; P=0.3636). At the 6-month follow-up, the values of LESP and 5-mBH in the BESG is more stable compared to those in the BSG (p<0.05). Immunohistochemistry for mouse anti-proliferating cell nuclear antigen (PCNA) and α-smooth muscle actin revealed alleviate inflammatory reaction peak in the BESG than in the BSG (p<0.05). Collagen proliferation was most severe after 6 months in the BSG (p<0.05). Cardia stent insertion was tolerated by all subjects, with similar stent migration rate of DES or BS (5.6% vs. 11.1%; P=0.3636). At the 6-month follow-up, the values of LESP and 5-mBH in the BESG is more stable compared to those in the BSG (p<0.05). Immunohistochemistry for mouse anti-proliferating cell nuclear antigen (PCNA) and α-smooth muscle actin revealed alleviate inflammatory reaction peak in the BESG than in the BSG (p<0.05). Collagen proliferation was most severe after 6 months in the BSG (p<0.05). ConclusionThe novel drug eluting cardia stent was more effective than bare stent for the treatment of this benign cardia stricture canine model. Further studies are required to assess if the recurrence rate is lower due to less inflammation and scarring in a long-term. The novel drug eluting cardia stent was more effective than bare stent for the treatment of this benign cardia stricture canine model. Further studies are required to assess if the recurrence rate is lower due to less inflammation and scarring in a long-term.

Application of the Newly Developed Stents in the Treatment of Benign Cardia Stricture: an Experimental Comparative Study

Abstract No. 106: The application of the newly developed drug-eluting stents for the treatment of benign cardia stricture dog models

Abstract No. 105: Biodegradable self-expanding stents for the treatment of benign cardia stricture in a dog model

Temporary Self-Expanding Cardia Stents for the Treatment of Achalasia:An Experimental Study in Dogs

A Newly-Designed Temporary Cardia Stent for the Treatment of Achalasia:An Experimental Study in Canine Models

Temporary Placement of a Paclitaxel or Rapamycin-Eluting Stent is Effective to Reduce Stenting Induced Inflammatory Reaction and Scaring in Benign Cardia Stricture Models.

Evaluation of biodegradable paclitaxel-eluting nanofibre-covered metal stents for the treatment of benign cardia stricture in an experimental model.

Biodegradable Rapamycin-Eluting Nano-Fiber Membrane-Covered Metal Stent Placement to Reduce Fibroblast Proliferation in Experimental Stricture in a Canine Model

[Efficacy and Safety of Digestive Tract Stent Placement under Direct Visual Endoscopy Without X-ray Monitoring in Treatment of Digestive Tract Stricture].

Sutureless Choledochoduodenostomy with an Intraluminal Degradable Stent in Dog Model.

Comparative observation on different intervention procedures in benign stricture of gastrointestinal tract

Establishment and Observation of Animal Model with Benign Proliferative Stenosis after Esophageal Stent Implantation

Temporary Partially-Covered Metal Stent Insertion in Benign Esophageal Stricture

Comparison Of Temporary Stent Insertion With Pneumatic Dilation Of The Same Diameter In The Treatment Of Achalasia Patients: A Retrospective Study

[Experimental Study of Preventing Postoperative Stenosis by Modifying Artificial Esophagus in Dogs].

Interventional procedure for benign and malignant stricture or obstruction of upper gastrointestinal tract

Comparison of Tissue Reaction with Three Different Endografts Used for Exclusion of Carotid Artery Aneurysm in a Dog Model.

Application progress of stent placement in esophageal malignant and benign stenosis

Comparison of the Occlusion of Experimental Craniojugular Saccular Aneurysms with Covered Stents

Prevention of Benign Esophageal Stent Restenosis : an Animal Experiment

Establishment of a canine model of carotid stenosis suitable for stenting or percutaneous transluminal angioplasty